These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 348417)

  • 1. The responses of Escherichia coli to nalidixic acid.
    Greenwood D; O'Grady F
    Chemotherapy; 1978; 24(4):249-58. PubMed ID: 348417
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampicin plus nalidixic acid: a rational combination for the treatment of urinary infection.
    Greenwood D; Andrew J
    J Antimicrob Chemother; 1978 Nov; 4(6):533-8. PubMed ID: 101503
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors governing the emergence of resistance to nalidixic acid in treatment of urinary tract infection.
    Greenwood D; O'Grady F
    Antimicrob Agents Chemother; 1977 Dec; 12(6):678-81. PubMed ID: 337890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of nalidixic acid activity on 3186 strains of Gram negative bacilli. Application to the treatment of urinary infections].
    Chamfeuil R; Curcier H
    Presse Med (1893); 1969 Nov; 77(48):1763-4. PubMed ID: 4903534
    [No Abstract]   [Full Text] [Related]  

  • 5. Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance.
    Greenwood D; Osman M; Goodwin J; Cowlishaw WA; Slack R
    J Antimicrob Chemother; 1984 Apr; 13(4):315-23. PubMed ID: 6233248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of mechanisms responsible for inoculum effects in the response of Escherichia coli to a variety of antibiotics.
    Greenwood D
    J Antimicrob Chemother; 1976 Mar; 2(1):87-95. PubMed ID: 6416
    [No Abstract]   [Full Text] [Related]  

  • 7. Nalidixic acid-resistant auxotrophs of Escherichia coli.
    Helling RB; Adams BS
    J Bacteriol; 1970 Nov; 104(2):1027-9. PubMed ID: 4923064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nalidixic acid (Wintomylon) and bacterial resistance to antibiotics in urinary tract infections].
    Makino M
    Hinyokika Kiyo; 1968 Jun; 14(6):351-6. PubMed ID: 4882490
    [No Abstract]   [Full Text] [Related]  

  • 9. Sulphadimidine and nalidixic acid therapy in urinary-tract infections in general practice.
    Brown PC; Donaghy MC; Dootson PH; Titcombe DH; MacLaren DM
    Practitioner; 1971 Dec; 207(242):819-26. PubMed ID: 4947233
    [No Abstract]   [Full Text] [Related]  

  • 10. Nalidixic acd-resistant mutants of Escherichia coli deficient in isocitrate dehydrogenase.
    Helling RB; Kukora JS
    J Bacteriol; 1971 Mar; 105(3):1224-6. PubMed ID: 4926678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antibiotic sensitivity of 100 isolates of Escherichia coli, with special reference to the domiciliary treatment of urinary tract infections.
    Anderson K
    Med J Aust; 1970 Aug; 2(9):409-11. PubMed ID: 4924022
    [No Abstract]   [Full Text] [Related]  

  • 12. Nalidixic acid in urinary infection.
    Neogy KN; De MS; Chatterjee ML
    Bull Calcutta Sch Trop Med; 1968 Jan; 16(1):11-2. PubMed ID: 4890385
    [No Abstract]   [Full Text] [Related]  

  • 13. [Resistance to nalidixic acid in tetracycline-resistant mutants of E. coli].
    Khanina MF; Gromova TG; Terekhov AA
    Antibiotiki; 1975; 20(12):1099-104. PubMed ID: 773284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Character of the effect of nalidixic acid (negram) on Escherichia coli strain 613].
    Planel'es KhKh; Andreeva AM; Moroz AF
    Antibiotiki; 1968 Jul; 13(7):617-20. PubMed ID: 4880236
    [No Abstract]   [Full Text] [Related]  

  • 15. Nalidixic acid.
    Bailey RR
    JAMA; 1977 Jun; 237(25):2720. PubMed ID: 577224
    [No Abstract]   [Full Text] [Related]  

  • 16. Observations on bacterial sensitivities to nalidixic acid and critical comments on the 6-centre survey.
    Brumfitt W; Pursell R
    Postgrad Med J; 1971 Sep; 47():Suppl:16-8. PubMed ID: 4939411
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of R-factor plasmids on host-cell responses to nalidixic acid I. Increased susceptibility of nalidixic acid-sensitive hosts.
    Crumplin GC; Smith JT
    J Antimicrob Chemother; 1981 Apr; 7(4):379-88. PubMed ID: 7019186
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical use of nalidixic acid. A review and some observations.
    Stamey TA; Nemoy NJ; Higgins M
    Invest Urol; 1969 May; 6(6):582-92. PubMed ID: 4976942
    [No Abstract]   [Full Text] [Related]  

  • 19. Are quinolone-resistant uropathogenic Escherichia coli less virulent?
    Vila J; Simon K; Ruiz J; Horcajada JP; Velasco M; Barranco M; Moreno A; Mensa J
    J Infect Dis; 2002 Oct; 186(7):1039-42. PubMed ID: 12232848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation affecting resistance of Escherichia coli K12 to nalidixic acid.
    Hrebenda J; Heleszko H; Brzostek K; Bielecki J
    J Gen Microbiol; 1985 Sep; 131(9):2285-92. PubMed ID: 3906038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.